tradmap

HSCS Earnings HeartSciences Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$80 -$40 $0 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $9300 $18600 2022 2023 2024 2025 2026
Revenue
Net income (annual)
-$9M -$5M $0 2022 2023 2024 2025 2026
Net income

Quarterly results

Diluted EPS (quarterly)
-$29 -$15 $0 Q1 '22 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25
EPS
Revenue (quarterly)
$0 $7350 $14700 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$3M -$1M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–18 of 18
Q2 20252025-10-31-2.102025-12-1510-Q
Q1 20252025-07-31-1.582025-09-1110-Q
FY 20252025-04-30-9.342025-07-2410-K
Q3 20252025-01-31-7.462025-03-1310-Q
Q2 20252024-10-31-4.882025-12-1510-Q
Q1 20252024-07-31-2.642025-09-1110-Q
FY 20252024-04-30-18.742025-07-2410-K
Q3 20252024-01-31-18.852025-03-1310-Q
Q2 20252023-10-31-29.232024-12-1610-Q
Q1 20252023-07-31-13.232024-09-1210-Q
FY 20242023-04-30-80.002024-07-2910-K
Q3 20242023-01-31-0.642024-03-1410-Q
Q2 20242022-10-31-0.492023-12-1410-Q
Q1 20242022-07-31-0.282023-09-1410-Q
FY 20232022-04-30-1.452023-07-1910-K
Q3 20232022-01-31-0.842023-03-1610-Q
Q2 20232021-10-31-0.462022-12-1510-Q
Q1 20232021-07-31-0.152022-09-1210-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.